speedrail.ru


NGM BIO STOCK

NGM Biopharmaceuticals Inc stock news, updates & related news. Find out why NGM Biopharmaceuticals Inc's (NGM) news sentiment is % more negative in. On Wednesday, NGM Biopharmaceuticals Inc (0IK:FRA) closed at , % above the 52 week low of set on Nov 21, week range. Today. Nov Analyst Forecast. According to 3 analysts, the average rating for NGM stock is "Strong Buy." The month stock price forecast is $, which is an increase of. $ ; Ticker. NGM ; Sector. Healthcare ; Trading on. NASDAQ ; Industry. Biotechnology & Drugs ; CEO. William Rieflin. NGM Biopharmaceuticals Reports a Successful NASH Trial Strong results on multiple measures put the company's drug candidate firmly in the NASH discussion.

NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for. Get the latest updates on NGM Biopharmaceuticals, Inc. Common Stock (NGM) after hours trades, after hours share volumes, and more. 49 minutes ago. Analyst's Opinion · Consensus Rating. NGM Biopharmaceuticals has received a consensus rating of Hold. · Price Target Upside/Downside. According to analysts'. Insiders who acquired US$k worth of NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) stock at an average price of. The Investor Relations website contains information about NGM Biopharmaceuticals, Inc.'s business for stockholders, potential investors, and financial. Industry, Biotechnology: Biological Products (No Diagnostic Substances) ; 1 Year Target, $ ; Today's High/Low, $/$ ; Share Volume, , Is NGM Biopharmaceuticals, Inc. a good stock to buy? 5 Wall Street analysts have issued ratings. Currently, 1 analysts rated NGM as Bullish, 0 rated it Bearish. NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of % and %, respectively, for the quarter ended September Do the numbers. The average price target for NGM Biopharmaceuticals Inc is $ This is based on 4 Wall Streets Analysts month price targets, issued in the past 3 months. NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic.

NGM Biopharmaceuticals, Inc. Stock price ; Related indices. Russell ; Mean consensus. OUTPERFORM ; Number of Analysts. 6 ; Last Close Price. USD ; Average. NGM Biopharmaceuticals Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, M ; Market Value, $M. View NGM Biopharmaceuticals, Inc. NGM stock quote prices, financial information, real-time forecasts, and company news from CNN. Is NGM Biopharmaceuticals Inc. stock A Buy? Several short-term signals, along with a general good trend, are positive and we conclude that the current level may. Find the latest NGM Biopharmaceuticals, Inc. (NGM) stock quote, history, news and other vital information to help you with your stock trading and investing. View the NGM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the NGM Biopharmaceuticals. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. View the latest NGM Biopharmaceuticals Inc. (NGM) stock price, news, historical charts, analyst ratings and financial information from WSJ. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. M USD. Avg Volume. The average number of.

Share Price. $; (As of Thursday Closing) · NGM Biopharmaceuticals General Information · Want detailed data on 3M+ companies? Get NGM Biopharmaceuticals Inc (NGM:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Research NGM Biopharmaceuticals' (Nasdaq:NGM) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. NGM Stock Data ; Market Cap M ; Float M ; Insiders Ownership % ; Institutions Ownership % ; Short Percent %. NGM Biopharmaceuticals, Inc. (US:NGM) has institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission .

Track Ngm Biopharmaceuticals Inc (NGM) Stock Price, Quote, latest community messages, chart, news and other stock related information. The NGM Biopharmaceuticals, Inc. stock price is currently $ with a total market cap valuation of $ M (M shares outstanding). The NGM. NGM - NGM Biopharmaceuticals, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGS). NGM · $ · Key details.

Top 10 Stocks to Get Rich in 2024 (Without Getting Lucky)

90 minute ticker cruise deals | earnings calendar app

8 9 10 11 12

se ltd stock fastest crypto mining app morn stock we fix it wpm stock forecast closing price of silver panetta splash stock jp morgan chase rates crypto exchanges in singapore us to cnd share price of dell how to read forex candlestick charts sonic prices what time does gamestop close on sunday residential address checker online casino with most payouts german stocks to buy taxbit app how much is it for a gram of gold

Copyright 2016-2024 Privice Policy Contacts SiteMap RSS